A Critical Analysis on Impact of Clinical Pharmacist based Medication Reconciliation Practice among Cancer Patients-A Prospective Interventional Study.
Keywords:
Medication Reconciliation, Poly Pharmacy, Cancer patients, adverse drug reactions, Drug Interactions, Medication Errors.Abstract
Medication Reconciliation is defined as the process where the health care providers work with the patients to document communicate the comprehensive medication information by complete medication list and then reconciling it against what patient has been actually intended to take or taking in order to identify the drug related problems like drug interactions, medication errors and adverse drug reactions. Cancer patients are categorized as vulnerable population as they have many risk factors even cancer patients have been administered by various therapies like chemotherapy, biological agents, hormone therapy, supportive therapy that can leads to poly pharmacy by increasing the risk of drug related problems so it is required to impose the medication reconciliation practice strictly to ensure whether medications are optimized or not and to achieve desired therapeutic outcomes and in promotion of rational practice of drug usage .The present study involves in detail study of anti-cancer drug usage through critical case and prescription analysis to identify, analyze and report the drug related problems during the course of treatment.261 patients were enrolled in the study. A total of 17 Adverse drug reactions were screened during study period with causality and severity assessment, 22 prescriptions comprised of potential drug interactions with 79medication errors .The present study clearly states the Impact and outcomes of clinical pharmacist based medication reconciliation practice in promotion of rational drug usage and in minimization of drug related problems.References
Herledan C, Baudouin A, Larbre V, Gahbiche A, Dufay E, Alquier I. Clinical and economic impact of medication reconciliation in cancer patients: a systematic review. Support Care Cancer. 2020;28:3557–3569.
Kraus SK, Sen S, Murphy M, Pontiggia L. Impact of a pharmacy technician-centered medication reconciliation program on medication discrepancies and implementation of recommendations. Pharm Pract. 2017;15:901. doi: 10.18549/PharmPract.2017.02.901.
Damlien L, Davidsen N, Nilsen M, Godø A, Moger TA, Viktil KK. Drug safety at admission to emergency department: an innovative model for PRIOritizing patients for MEdication reconciliation (PRIOMER) Eur J Emerg Med. 2017;24:333–339.
Son H, Kim J, Kim C, Ju J, Lee Y, Rhie SJ. Pharmacist-led interdisciplinary medication reconciliation using comprehensive medication review in gynaecological oncology patients: a prospective study. Eur J Hosp Pharm. 2018;25(1):21–25.
Weingart SN, Cleary A, Seger A, Eng TK, Saadeh M, Gross A, et al. Medication reconciliation in ambulatory oncology. Jt Comm J Qual Patient Saf. 2007;33(12):750–757.
Vega TG-C, Sierra-Sánchez JF, Martínez-Bautista MJ, García-Martín F, Suárez-Carrascosa F, Baena-Cañada JM. Medication reconciliation in oncological patients: a randomized clinical trial. J Manag Care Spec Pharm. 2016;22:734–740.
Duffy AP, Bemben NM, Li J, Trovato J. Facilitating home hospice transitions of care in oncology: evaluation of clinical pharmacists' interventions, hospice program satisfaction, and patient representation rates. Am J Hosp Palliat Care. 2018;35(9):1181–1187. 8. Nguyen PAA, Enwere E, Gautreaux S, Lin H, Tverdek F, Lu M, et al. Impact of a pharmacy-driven transitions-of-care program on postdischarge healthcare utilization at a national comprehensive cancer center. Am J Health Syst Pharm. 2018;75:1386–1393.
Taché SV, Sönnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 2011;45:977–89. 10.1345/aph.1P627.
Azim M, Khan A, Khan TM, et al.. A cross-sectional study: medication safety among cancer in-patients in tertiary care hospitals in KPK, Pakistan. BMC Health Serv Res 2019;19:583. 10.1186/s12913-019-4420-7.
Dorothy A, Yadesa TM, Atukunda E. Prevalence of medication errors and the associated factors: a prospective observational study among cancer patients at Mbarara Regional Referral Hospital. Cancer Manag Res 2021;13:3739–48. 10.2147/CMAR.S307001.
Baker GR, Norton PG, Flintoft V, et al.. The Canadian adverse events study: the incidence of adverse events among hospitalized patients in Canada. CMAJ 2004;170:1678–86. 10.1503/cmaj.1040498.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
